All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-CQ0043 | Anti-BCAM (G253) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | G253 | Human | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ3467 | Anti-BCAM (G253) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | G253 | Human | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY2616 | Anti-BCAM (G418) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | G418 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY5869 | Anti-BCAM (G418) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | G418 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ0027 | Anti-BCAM (BRIC221) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | BRIC221 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ0028 | Anti-BCAM (CBWJC-0378) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBWJC-0378 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ0029 | Anti-BCAM (CBWJC-0379) h(41BB-CD3ζ) CAR, pCDCAR1 | CBWJC-0379 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |||
CAR-WJ2319 | Anti-BCAM (BRIC221) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | BRIC221 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ2320 | Anti-BCAM (CBWJC-0378) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBWJC-0378 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ2321 | Anti-BCAM (CBWJC-0379) h(CD28-CD3ζ) CAR, pCDCAR1 | CBWJC-0379 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION